Cargando…
Edaravone and mitochondrial transfer as potential therapeutics for vanishing white matter disease astrocyte dysfunction
INTRODUCTION: Previous research has suggested that vanishing white matter disease (VWMD) astrocytes fail to fully differentiate and respond differently to cellular stresses compared to healthy astrocytes. However, few studies have investigated potential VWMD therapeutics in monoculture patient‐deriv...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401142/ https://www.ncbi.nlm.nih.gov/pubmed/36971196 http://dx.doi.org/10.1111/cns.14190 |